Single Injection of Cross-Linked Hyaluronate in Knee Osteoarthritis: A 52-Week Double-Blind Randomized Controlled Trial

Background: to compare the 52-week effectiveness and safety between HYAJOINT Plus (HJP) and Durolane in knee osteoarthritis (OA) treatment. Methods: consecutive patients received a single injection of 3 mL HJP or Durolane. The primary outcome was a visual analog scale (VAS) pain measurement at 26 we...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Po-Yen, Li, Chung-Yi, Li, Chia-Lung, Kuo, Li-Chieh, Su, Wei-Ren, Jou, I-Ming, Wu, Po-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504468/
https://www.ncbi.nlm.nih.gov/pubmed/36145530
http://dx.doi.org/10.3390/pharmaceutics14091783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504468/
https://www.ncbi.nlm.nih.gov/pubmed/36145530
http://dx.doi.org/10.3390/pharmaceutics14091783

Ejemplares similares